Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ryan Specialty Holdings (RYAN) Gains from Sales and Divestitures (2021 - 2024)

Historic Gains from Sales and Divestitures for Ryan Specialty Holdings (RYAN) over the last 4 years, with Q2 2024 value amounting to $627302.0.

  • Ryan Specialty Holdings' Gains from Sales and Divestitures fell 6429.2% to $627302.0 in Q2 2024 from the same period last year, while for Jun 2024 it was $627302.0, marking a year-over-year decrease of 6429.2%. This contributed to the annual value of $2.1 million for FY2023, which is 1552.5% down from last year.
  • Per Ryan Specialty Holdings' latest filing, its Gains from Sales and Divestitures stood at $627302.0 for Q2 2024, which was down 6429.2% from $9449.0 recorded in Q1 2024.
  • In the past 5 years, Ryan Specialty Holdings' Gains from Sales and Divestitures registered a high of $2.5 million during Q4 2022, and its lowest value of $7074.0 during Q1 2023.
  • In the last 4 years, Ryan Specialty Holdings' Gains from Sales and Divestitures had a median value of $1.5 million in 2021 and averaged $1.3 million.
  • Its Gains from Sales and Divestitures has fluctuated over the past 5 years, first surged by 35769.75% in 2022, then tumbled by 9561.05% in 2023.
  • Ryan Specialty Holdings' Gains from Sales and Divestitures (Quarter) stood at $1.3 million in 2021, then surged by 92.78% to $2.5 million in 2022, then decreased by 15.53% to $2.1 million in 2023, then plummeted by 70.35% to $627302.0 in 2024.
  • Its Gains from Sales and Divestitures stands at $627302.0 for Q2 2024, versus $9449.0 for Q1 2024 and $2.1 million for Q4 2023.